Tuesday April 6, 9:48 am Eastern Time
Company Press Release
BioNet Technologies Launches Animal911.com
JUPITER, FL--(BW HealthWire)--April 6, 1999--BioNet Technologies, Inc. (OTC BB:BNTK - news) announced today that it has launched its e-commerce venture, Animal911.com.
Animal911.com will provide a free rapid search service to the public for all veterinarians within the United States. Animal911.com will provide to veterinarians reasonably priced Internet and web page services. Veterinarians will be able to have simple web pages for pennies a day, or for a reasonable cost, elaborate full color, animated web pages. The veterinarian can offer their clients bulletin boards, e-mail or fax reminders, monthly specials or service reminders. Directional maps to the clinic can be provided. Animal911.com will provide services to suit the beginner to the most computer savvy. In addition, Animal911.com will offer advertising space, a community bulletin board, and links for related services.
According to Alan Schafler, President of BioNet Technologies, ''Animal911.com is another example of BioNet's commitment to e-commerce, and is in concert with the strategic focus of our corporate activities. Animal911.com is critical, as BioNet becomes a significant force in the animal health and related industries with the development of our Immune Technologies and GreenGold companies. It is very satisfying to be at the forefront of curing and preventing animal diseases, and the resolution of worldwide animal waste disposal, water treatment, and atmospheric problems. The launch of Animal911.com and other e-commerce ventures of BioNet are important factors in our ability to generate income and recognition at an accelerated rate.''
Immune Technologies is developing proprietary products utilizing their innovative new ''Immune Modulation Technology''. The technology treats microbial infections by enhancing the patient's immune system, enabling the patient, in effect, to cure itself. ITI's products will be marketed under the trade name IMOD(tm) and have proven extremely effective in clinical trials and are being submitted to the USDA for approval in veterinary applications. Diseases affecting horses, dogs, cats, cows, and pigs are being targeted.
GreenGold International, BioNet's other subsidiary, owns patents relating to the commercial production of duckweed, a water plant which produces protein superior to soy beans at rates 10 times faster than soy beans and which has been used globally as a viable alternative for treating nitrogen rich waste water. The GreenGold technology provides for the integration of its duckweed production units into the waste disposal systems of hog farms. This technology can be expanded to other farm animal waste disposal, the elimination of waste lagoons, and the treatment of waste generated by cities and rural communities. The system would be extremely effective where the high cost of conventional systems is prohibitive, and will be an effective solution to the huge environmental problems with applications for municipal and industrial water and waste treatment facilities. GreenGold will be developing its own e-commerce site, which will effectively demonstrate this powerful system and unique Aquameal(tm) products.
BioNet Technologies, Inc. is a biotechnology company headquartered in Jupiter, Florida. The company is focused on growth through the acquisition of strategically relevant, emerging growth biotech companies and products and through internal growth of its business units. For more information contact Timothy Miles at 843-686-5590.
Certain statements in this press release constitute ''forward-looking statements'' within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks and uncertainties, including the ability of the Company and its subsidiaries to successfully market their products to their target markets, and other factors which may cause the actual results, performance or achievements of the company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statement.
--------------------------------------------------------------------------------
Contact:
BioNet Technologies, Jupiter
Timothy Miles, 843/686-5590
--------------------------------------------------------------------------------
More Quotes and News: Bionet Technologies Inc (OTC BB:BNTK - news)
Related News Categories: biotech, environmental, medical/pharmaceutical |
